Influenza vaccine contains antigenic proteins produced through recombinant dna technology
Answers
Answered by
3
A recombinant vaccine is a vaccine produced through recombinant DNA technology. This involves inserting the DNA encoding an antigen (such as a bacterial surface protein) that stimulates an immune response into bacterial or mammalian cells, expressing the antigen in these cells and then purifying it from them.
Similar questions
Math,
6 months ago
English,
6 months ago
Business Studies,
1 year ago
Computer Science,
1 year ago
English,
1 year ago
Science,
1 year ago